The role and efficacy of gilteritinib

GilteritinibA kinase inhibitor drug, used to treat a certain type of acute myeloid leukemia (AML) that worsens or relapses after treatment with other chemotherapy drugs. It works by blocking the effects of a naturally occurring substance that may be necessary to help cancer cells multiply.

Gi Ruitinib is a small molecule that inhibits multiple receptor tyrosine kinases, includingFMSlike tyrosine kinase3 (FLT3). Giritinibdemonstrated exogenous expressionFLT3 (includingFLT3-ITD, tyrosine kinase domain mutation(TKD) The ability of FLT3-D835Y and FLT3-ITD-D835Y) inhibits FLT3 receptor signaling and proliferation, and it induces apoptosis in leukemia cells expressing FLT3-ITD.

GIRItinib may cause a group of serious or life-threatening symptoms called differentiation syndrome. Doctors will monitor carefully to see if this syndrome is developing. Call your doctor right away if you develop any of the following symptoms, including fever, cough, rash, sudden weight gain, dizziness, decreased urination, swelling of arms or legs, shortness of breath, difficulty breathing, chest or bone pain. These symptoms may appear as early as 3 months after starting treatment with GIRIS. At the first sign of differentiation syndrome, your doctor will prescribe medications to treat the syndrome and may tell you to stop taking geritinib for a period of time. There are many versions of generic drugs, priced at about three to four thousand per box. If you want to get more high-quality information, you can contact YaoDe. YaoDe will do its best to learn more about high-quality overseas drugs for you.

xa0

xa0

xa0